Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
Florence Robert-Gangneux
1 , Valeria Meroni
1, Damien Dupont, Françoise Botterel, José M. Aguado Garcia
2, Marie-Pierre Brenier-Pinchart, Isabelle Accoceberry, Hamdi Akan
2, Isabella Abbate, Katia Boggian, Fabrizio Bruschi
2, Jordi Carratalà
2, Miruna David
2, Lubos Drgona
2, Olgica Djurković-Djaković, Maria Carmen Farinas, Francesca Genco, Effrossyni Gkrania-Klotsas
2, Andreas H. Groll
2, Edward Guy, Cédric Hirzel, Nina Khanna, Özgür Kurt
1, Lia Monica Junie
1, Tiziana Lazzarotto, Oscar Len
2, Nicolas J. Mueller, Patricia Munoz
2, Zoi Dorothea Pana
2, Emmanuel Roilides
2, Tijana Stajner, Christian van Delden, Isabelle Villena
1, Hervé Pelloux
1, and Oriol Manuel
2
Author affiliations: Université Rennes, Rennes, France (F. Robert-Gangneux); Centre Hospitalier Universitaire de Rennes, Rennes (F. Robert-Gangneux); European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland (V. Meroni, J.M. Aguado Garcia, F. Bruschi, J. Carratalà, M. David, L. Drgona, E. Gkrania-Klotsas, A.H. Groll, Ö. Kurt, L.M. Junie, O. Len, P. Munoz, Z.D. Pana, E. Roilides, I. Villena, H. Pelloux, O. Manuel); University of Pavia, Pavia, Italy (V. Meroni, F. Genco); Hôpital de la Croix-Rousse, Lyon, France (D. Dupont); Université Claude Bernard Lyon, Lyon (D. Dupont); Centre Hospitalier Universitaire Henri Mondor, Creteil, France (F. Botterel); University Hospital 12 de Octubre Universidad Complutense, Madrid, Spain (J.M. Aguado Garcia, H. Akan); Centre Hospitalier Universitaire Grenoble-Alpes, Grenoble, France (M.-P. Brenier-Pinchart); Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France (I. Accoceberry); Ankara University Cebeci Hospital, Ankara, Turkey (H. Akan); Lazzaro Spallanzani National Institute for Infectious Diseases, Rome, Italy (I. Abbate); St. Gallen Cantonal Hospital, St. Gallen, Switzerland (K. Boggian); Pisa University, Pisa, Italy (F. Bruschi); Bellvitge University Hospital-IDIBELL University of Barcelona, Barcelona, Spain (J. Carratalà); Queen Elizabeth Hospital, Birmingham, UK (M. David); Comenius University, Bratislava, Slovakia (L. Drgona); National Cancer Institute, Bratislava (L. Drgona); University of Belgrade, Belgrade, Serbia (O. Djurković-Djaković, T. Stajner); Hospital Universitario Marques de Valdecilla, Santander, Spain (M.C. Farinas); University of Cantabria, Santander (M.C. Farinas); Addenbrooke’s Hospital, Cambridge, UK (E. Gkrania-Klotsas); University Children’s Hospital Münster, Münster, Germany (A.H. Groll); Singleton Hospital, Swansea, Wales, UK (E. Guy); Bern University Hospital, Bern, Switzerland (C. Hirzel); University of Bern, Bern (C. Hirzel); Universitätsspital, Basel (N. Khanna); Acibadem Mehmet Ali Aydinlar, Istanbul, Turkey (Ö. Kurt); University of Medicine and Pharmacy Iuliu Hatieganu, Cluj Napoca, Romania (L.M. Junie); St. Orsola-Malpighi General Hospital, Bologna, Italy (T. Lazzarotto); University of Bologna, Bologna (T. Lazzarotto); Hospital Universitari Vall d’Hebron, Barcelona (O. Len); Zurich University Hospital, Zurich, Switzerland (N.J. Mueller); University of Zurich, Zurich (N.J. Mueller); Hospital General Gregorio Maranon, Madrid, Spain (P. Munoz); Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece (Z.D. Pana, E. Roilides); University Hospitals Geneva, Geneva, Switzerland (C. van Delden); Centre Hospitalier Universitaire de Reims, Reims, France (I. Villena); University Hospital, Lausanne, Switzerland (O. Manuel); University of Lausanne, Lausanne (O. Manuel)
Main Article
Table 1
Characteristics of 87 transplant patients with toxoplasmosis, according to clinical presentation, Europe, 2010–2014*
Variables
|
Clinical type |
p value
|
Cerebral
|
Ocular
|
Disseminated
|
Pulmonary
|
Fever alone
|
No signs
|
No. (%) patients
|
13 (15)
|
4 (5)
|
19 (22)
|
10 (11)
|
10 (11)
|
31 (36)
|
|
Patient age, y, mean ± SE
|
37.0 ± 7.7
|
60.7 ± 0.8
|
47.8 ± 5.6
|
53.1 ± 4.8
|
35.5 ±4.4
|
46.4 ± 4.2
|
<0.0001
|
Time graft/diagnosis, wk, mean ± SE
|
123 ± 151
|
313 ± 175
|
163 ± 124
|
19 ± 11
|
73 ± 43
|
99 ± 51
|
<0.05
|
Diagnosis by, no. (%)
|
|
|
|
|
|
|
|
PCR |
13 (100) |
3 (75) |
17 (89) |
9 (90) |
9 (90) |
26 (84) |
<0.001 |
Serology |
3 (23) |
3 (75) |
9 (47) |
2 (20) |
5 (50) |
5 (16) |
0.2278 |
Imaging |
12 (92) |
3 (75) |
8 (42) |
7 (70) |
0 |
2 (6) |
<0.01 |
Microscopy
|
1 (8)
|
0
|
6 (32)
|
1 (10)
|
0
|
0
|
<0.01
|
Graft type, no. (%) |
|
|
|
|
|
|
<0.05 |
Liver, n = 8 |
1 (8) |
1 (25) |
3 (16) |
2 (20) |
0 |
1 (3) |
|
Kidney, n = 9 |
1 (8) |
1 (25) |
1 (5) |
2 (20) |
3 (30) |
1 (3)† |
|
Heart, n = 12 |
0 |
1 (25) |
5 (26) |
0 |
2 (20) |
4 (13)‡ |
|
Allo-HSC, n = 58
|
11 (85)
|
1 (25)
|
10 (53)
|
6 (60)
|
5 (50)
|
25 (81)§
|
|
No. with mismatch, n = 11
|
0
|
1 (25)
|
5 (26)
|
1 (10)
|
4 (40)
|
0
|
<0.05
|
Survival, no. (%) |
|
|
|
|
|
|
|
2 mo |
5 (38) |
4 (100) |
13 (68) |
5 (50) |
10 (100) |
24 (77) |
<0.0001 |
6 mo |
2 (15) |
4 (100) |
10 (53) |
5 (50) |
7 (70) |
18 (58) |
<0.001 |
Main Article
Page created: July 18, 2018
Page updated: July 18, 2018
Page reviewed: July 18, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.